Indian drugmakers fret over FDA crackdown; Lanxess expands Saltigo site;

> Specialty chemicals company Lanxess is investing about €60 million ($65 million) to expand a Saltigo site in Leverkusen, Germany. Report

> Indian drugmakers discussed FDA concerns at a meeting recently, with experts acknowledging that some companies need to improve operations to avoid getting Form 483s from the agency. Report

> CDMO Lonza argues the industry is lagging in its use of electronic documentation for quality control. Report